Protara Therapeutics (TARA) Earnings Date, Estimates & Call Transcripts $3.16 +0.10 (+3.27%) Closing price 08/4/2025 04:00 PM EasternExtended Trading$3.16 +0.00 (+0.16%) As of 08/4/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Protara Therapeutics Earnings Summary Protara Therapeutics posted Q1 2025 earnings on May 8, 2025, reporting an EPS of -$0.29, which beat analysts' consensus estimates of -$0.47 by $0.18. With a trailing EPS of -$1.72, Protara Therapeutics' earnings are expected to decrease next year, from ($3.32) to ($3.40) per share. Upcoming Q2 Earnings DateAug. 5EstimatedConsensus EPS (May. 8) -$0.47 Actual EPS (May. 8) -$0.29 Beat By $0.18 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)TARA Upcoming EarningsProtara Therapeutics' Q2 2025 earnings is scheduled for Tuesday, August 5, 2025, with a conference call scheduled on Monday, August 11, 2025 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Protara Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Protara Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTARA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Protara Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.53-$0.37-$0.45Q2 20252-$0.55-$0.44-$0.50Q3 20252-$0.57-$0.52-$0.55Q4 20252-$0.60-$0.60-$0.60 FY 2025 8 -$2.25 -$1.93 -$2.09 Q1 20261-$0.57-$0.57-$0.57Q2 20261-$0.60-$0.60-$0.60Q3 20261-$0.68-$0.68-$0.68Q4 20261-$0.77-$0.77-$0.77 Protara Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/5/2025(Estimated)--$0.43------5/8/2025Q1 2025-$0.47-$0.29+$0.18-$0.29--3/12/2025Q4 2024-$0.57-$0.48+$0.09-$0.48--11/12/2024--$0.50-$0.50--$0.50--8/6/2024--$0.82-$0.45+$0.37-$0.45--5/2/2024Q1 2024-$0.99-$0.97+$0.02-$0.97--3/13/2024Q4 2023-$1.03-$0.90+$0.13-$0.90--11/3/2023Q3 2023-$1.10-$0.87+$0.23-$0.87-- Protara Therapeutics Earnings - Frequently Asked Questions When is Protara Therapeutics' earnings date? Protara Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 5th, 2025 based off last year's report dates. Learn more on TARA's earnings history. Did Protara Therapeutics beat their earnings estimates last quarter? In the previous quarter, Protara Therapeutics (NASDAQ:TARA) reported ($0.29) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.47) by $0.18. Learn more on analysts' earnings estimate vs. TARA's actual earnings. How much profit does Protara Therapeutics generate each year? Protara Therapeutics (NASDAQ:TARA) has a recorded net income of -$44.60 million. TARA has generated -$1.72 earnings per share over the last four quarters. What is Protara Therapeutics' EPS forecast for next year? Protara Therapeutics' earnings are expected to decrease from ($3.32) per share to ($3.40) per share in the next year. More Earnings Resources from MarketBeat Related Companies SIGA Earnings Results TRML Earnings Results ERAS Earnings Results MBX Earnings Results CGEM Earnings Results KOD Earnings Results PGEN Earnings Results RGNX Earnings Results SVRA Earnings Results KMDA Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings: What Comes Next and How to Play ItApple Stock: Big Earnings, Small Move—Time to Buy?Why Robinhood Just Added Upside Potential After a Q2 Earnings DipMicrosoft Blasts Past Earnings—What’s Next for MSFT?Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?Spotify's Q2 Earnings Plunge: An Opportunity or Ominous Signal?RCL Stock Sinks After Earnings—Is a Buying Opportunity Ahead? This page (NASDAQ:TARA) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.